CareCloud, Inc.
No enriched coverage for $CCLD in the last 7 days.
No SEC Form 4 filings for $CCLD in the last 30 days.
See all $CCLD insider activity →CareCloud (CCLD) reported Q2 2026 revenue of $31.9 million, up 16% year over year, mainly from the Medsphere acquisition. GAAP net income was $1.1 million, with breakeven GAAP EPS. Adjusted EBITDA was $5.9 million. The company redeemed $38.2 million of Series B preferred stock using a $50 million credit facility and reaffirmed FY2026 guidance: revenue $128-$132 million and adjusted EBITDA $29-$31 million.
CareCloud, Inc. reported 16% Q2 2026 revenue growth, citing Medsphere integration and a shift to recurring technology-enabled solutions at 75% of revenue. The company fully redeemed Series B preferred stock, removing about $3.3M annual dividends, and reaffirmed full-year 2026 guidance. It also acquired Empower Healthcare and Compliance Partners to expand into compliance and audit defense, and set a $60M ATM equity program.
CareCloud, Inc. (CCLD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 CareCloud Reports Second Quarter 2026 Results Revenue Grows 16%; Ninth Consecutive Quarter of Positive GAAP Net Income SOMERSET, N.J., August 6, 2026 (GLOBE NEWSWIRE)— CareCloud, Inc. (Nasdaq: CCLD), a leader in AI-powered healthcare technology and revenue cycle mana
Recent CCLD coverage spans financial news, earnings and corporate actions.
Capital structure simplification plus FY2026 guidance and AI/recurring revenue mix shift are likely to drive near-term sentiment and positioning.
CareCloud, Inc. reported 16% Q2 2026 revenue growth, citing Medsphere integration and a shift to recurring technology-enabled solutions at 75% of revenue. The company fully redeemed Series B preferred stock, removing about $3.3M annual dividends, and reaffirmed full-year 2026 guidance. It also acquired Empower Healthcare and Compliance Partners to expand into compliance and audit defense, and set a $60M ATM equity program.
The 8-K provides a fresh earnings datapoint plus reiterated FY targets, with profitability and guidance as the key near-term drivers.
The 8-K discloses covenant/definition changes in CareCloud’s credit facility, which can affect liquidity headroom and acquisition flexibility.
Board/officer changes plus a newly adopted equity incentive plan can shift internal incentives and near-term governance expectations.
AlphAI scores every news story that mentions CCLD with an AI model for sentiment and relevance, and aggregates insider trades from CareCloud, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
CareCloud (CCLD) reported Q2 2026 revenue of $31.9 million, up 16% year over year, mainly from the Medsphere acquisition. GAAP net income was $1.1 million, with breakeven GAAP EPS. Adjusted EBITDA was $5.9 million. The company redeemed $38.2 million of Series B preferred stock using a $50 million credit facility and reaffirmed FY2026 guidance: revenue $128-$132 million and adjusted EBITDA $29-$31 million.
10 min readCareCloud, Inc. reported 16% Q2 2026 revenue growth, citing Medsphere integration and a shift to recurring technology-enabled solutions at 75% of revenue. The company fully redeemed Series B preferred stock, removing about $3.3M annual dividends, and reaffirmed full-year 2026 guidance. It also acquired Empower Healthcare and Compliance Partners to expand into compliance and audit defense, and set a $60M ATM equity program.
7 min readCareCloud, Inc. (CCLD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 CareCloud Reports Second Quarter 2026 Results Revenue Grows 16%; Ninth Consecutive Quarter of Positive GAAP Net Income SOMERSET, N.J., August 6, 2026 (GLOBE NEWSWIRE)— CareCloud, Inc. (Nasdaq: CCLD), a leader in AI-powered healthcare technology and revenue cycle mana
4 min readCareCloud, Inc. (CCLD) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 ex10-1.htm EX-10.1 Exhibit 10.1 FIRST AMENDMENT TO CREDIT AGREEMENT dated as of June 25, 2026, effective as of May 6, 2026 among CARECLOUD, INC. , a Delaware corporation, as Borrower, and The Lenders Party Hereto and CITIZENS BANK, N.A. , as Administrative Agent, Sole L
3 min readCareCloud, Inc. (CCLD) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-3.1 2 ex3-1.htm EX-3.1 Exhibit 3.1 CareCloud, Inc. 2026 Equity Incentive Plan Adopted by the Board of Directors: March 24, 2026 1. General. (a) Eligible Award Recipients. The persons eligible to receive Awards are Employees, Directors and Consultants. (b) Available Awards. The
4 min readCareCloud (Nasdaq: CCLD, CCLDO) announced monthly cash dividends for its 8.75% Series A and Series B preferred shares for January, February, and March 2026. The company also declared an additional dividend for Series B to address an arrearage. Series A was mandatorily converted and delisted in March 2025, while Series B continues to trade under CCLDO with a declining redemption price schedule.
2 min readPlatform strengthens physician alignment and referral management. live presentation scheduled for October ...
3 min readCareCloud ( NASDAQ:CCLD ) , a healthcare technology firm specializing in cloud-based solutions and revenue cycle management ( RCM ) , reported Q2 2025 earnings on August 5, 2025. The key headline: positive GAAP earnings per share ( EPS ) for the first time since going public in 2014, with ...
2 min readSOMERSET, N.J., July 10, 2025 ( GLOBE NEWSWIRE ) -- CareCloud, Inc. ( Nasdaq: CCLD, CCLDO ) ( "CareCloud" or the "Company" ) , a leader in AI-powered healthcare technology and revenue cycle management solutions, today announced that its common stock rose approximately 70% during the second ...
3 min readSOMERSET, N.J., July 02, 2025 ( GLOBE NEWSWIRE ) -- CareCloud, Inc. ( Nasdaq: CCLD, CCLDO ) ( "CareCloud" or the "Company" ) , a leader in AI-driven healthcare technology solutions for medical practices and health systems nationwide, today announced that it has been added to the Russell ...
3 min read
